Evaluating the Impact of Patient-Centered Oncology Care

NCT02110758 | Completed Results

• 1 other identifier: IH-12-11-4383
• Study Type: observational
• Target: 125,250
• Locations: 1 country
• Sites: 1

Brief Summary

The National Committee for Quality Assurance has worked with the National Coalition for Cancer Survivorship, the American Society of Clinical Oncology, Oncology Management Services, Independence Blue Cross, and RAND, as well as a broader multi-stakeholder advisory group, to define the Patient-Centered Oncology Care model. The purpose of this project was to pilot and evaluate this model. Specific research questions were:

1. 1.Does Patient-Centered Oncology Care improve patient experiences and quality of care? Does it reduce undesirable events like emergency department visits and hospital stays?
2. 2.How does adoption of Patient-Centered Oncology Care vary across a variety of practices and what factors affect adoption?

Conditions

Neoplasms

Keywords

Patient Care Management; Patient Care Planning; Patient-Centered Care; Patient Care Team; Advance Care Planning; Delivery of Health Care; Evidence-based Practice; Health Care Costs; Health Care Quality, Access, and Evaluation; Quality of Health Care; Neoplasms; Medical Oncology

Outcome Measures

Primary Outcomes (3)

• Change in Patient Experience From Baseline to Follow up

  Patient experience survey composite scores were evaluated in the pilot practice group and in the comparison practice group during the intervention period and the follow-up period using a modified version of the cancer CAHPS patient survey. We calculated survey composite scores on a 0-100 scale using proportional scoring and the summated rating method based on the CAHPS macro.This method calculates the mean responses to each survey item in the composite, after transforming each response to a 0-100 scale (100 representing the most positive response on any given item response scale; 0 representing the least positive). For example, on a Yes/No response scale, if "Yes" represents the most positive response, then Yes= 100 and No = 0; on an Always/Usually/Sometimes/Never response scale, if "Always" represents the most positive response, then Always = 100, Usually = 67, Sometimes = 33 and Never = 0. A higher score means that practices were rated more positively for care on that item.

  At baseline and 24 months follow up

• Change in Quality of Care From Baseline to Follow up: Percentage of Patients Receiving Recommended Care

  Quality measure performance rates were evaluated in the pilot practice group during the baseline period and the follow-up period. Data were abstracted from medical records for a sample of patients diagnosed with an invasive malignancy within previous 2 years and with at least 2 visits to the practice in the previous six months at baseline and at 36 months follow-up.

  Two years prior to baseline and at 36 months follow-up

• Change in Health Care Utilization From Baseline to Follow up

  Per member per month hospitalizations, emergency department visits, primary care visits and specialist visits were evaluated in the pilot group and in the comparison group using insurance claims data during the baseline, start-up, intervention and follow-up periods.

  Two years prior to baseline and at 36 months follow up

Study Arms (5)

Pilot Practices Patient Survey Cohort

Patients with any active drug therapy treatment for cancer receiving care at pilot practice in southeastern Pennsylvania

Other: Pilot of Patient-Centered Oncology Care

Comparison Practices Patient Survey Cohort

Patients with any active drug therapy treatment for cancer receiving care at comparison practice in southeastern Pennsylvania

Pilot Practices Utilization Cohort

Patients with an evaluation \& management claim attributed to a medical oncology pilot practice in southeastern Pennsylvania

Other: Pilot of Patient-Centered Oncology Care

Comparison Practices Utilization Cohort

Patients with an evaluation \& management claim attributed to a medical oncology comparison practice in southeastern Pennsylvania

Pilot Practices Quality Measures Cohort

Patients with a new diagnosis of cancer in the past two years

Other: Pilot of Patient-Centered Oncology Care

Interventions

Pilot of Patient-Centered Oncology Care OTHER

Patient-Centered Oncology Care addresses six domains: track \& coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track \& coordinate care, and measure and improve performance.

Pilot Practices Patient Survey Cohort; Pilot Practices Quality Measures Cohort; Pilot Practices Utilization Cohort

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population consisted of patients with cancer who received their cancer care from oncology practices. We attributed patients to the study practices (pilot or comparison practices) based on the plurality of office visits for cancer diagnoses. We used sensitivity analyses to investigate other attribution rules, such as the majority of such office visits.

You may qualify if:

• Patients:
• Diagnosis of cancer
• Receives care at a pilot or comparison oncology practice located in southeastern Pennsylvania that accepts patients with Independence Blue Cross health insurance

Sponsors & Collaborators

• National Committee for Quality Assurance: lead
• American Society of Clinical Oncology: collaborator
• Independence Blue Cross: collaborator
• National Coalition for Cancer Survivorship: collaborator
• Oncology Management Services: collaborator
• RAND: collaborator

Study Sites (1)

National Committee for Quality Assurance

Washington D.C., District of Columbia, 20005, United States

Location

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

• Title: Sarah Hudson Scholle
• Organization: National Committee for Quality Assurance

scholle@ncqa.org

202-955-1726

Study Officials

• Sarah H Scholle, DrPH, MPH

  National Committee for Quality Assurance

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 31, 2014
• First Posted: April 10, 2014
• Study Start: February 1, 2014
• Primary Completion: January 1, 2017
• Study Completion: January 1, 2017
• Last Updated: March 9, 2021
• Results First Posted: March 9, 2021

Record last verified: 2021-03

Locations

US (1)